MSDH-C is a potent inhibitor of glycosphingolipid biosynthesis. At 10 μM decreases de novo ceramide biosynthesis by about 90%.
 Synthesis of potential inhibitors of the glycosphingolipid biosynthesis: G. Brenner-Weiss, et al.; Tetrahedron 48, 5855 (1992)  1-Methylthiodihydroceramide, a novel analog of dihydroceramide, stimulates sphinganine degradation resulting in decreased de novo sphingolipid biosynthesis: G. van Echten-Deckert, et al.; J. Biol. Chem. 273, 1184 (1998)
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.